Cardiac biomarkers in patients suspected of acute myocardial infarction: Where do we stand and where do we go?
One year ago, in this journal, I questioned whether by using the actual biomarker (mainly sensitive cardiac troponin [cTn] assays) we were close to reaching the Holy Grail – and I…
